AUF1 and HuR: possible implications of mRNA stability in thyroid function and disorders
详细信息 查看全文
- 作者：Bogusz Trojanowicz (1)
Henning Dralle (1)
Cuong Hoang-Vu (1) - 刊名：Thyroid Research
- 出版年：2011
- 出版时间：December 2011
- 年：2011
- 卷：4
- 期：1-supp
- 全文大小：819KB
- 参考文献：1. Brewer G: An A+U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. / Mol Cell Biol 1991, 11:2460鈥?466.
2. DeMaria CT, Brewer G: AUF1 binding affinity to A+U-rich elements correlaates with rapid mRNA degradation. / J Biol Chem 1996, 271:12179鈥?2184. CrossRef
3. Good PJ: A conserved family of elav-like genes in vetebrates. / Proc Natl Acad Sci U S A 1995, 92:4557鈥?561. CrossRef
4. Ma WJ, Cheng S, Campell C, Wrignt A, Furneaux H: Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. / J Biol Chem 1996, 271:8144鈥?151. CrossRef
5. Loflin P, Chen CYA, Shyu AN: Unraveling a cytoplasmic rolr for hnRNPD in the in vivo mRNA destabilization directed by the AU-rich element. / Genes Dev 1999, 13:1884鈥?897. CrossRef
6. Zhang W, Wagner BJ, Ehrenmann K, Schaefer AW, DeMaria CT, Crater D, DeHaven K, Long L, Brewer G: Purification, characterization and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. / Mol Cell Biol 1993, 13:7652鈥?665.
7. Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M: HuR regulated Cyclin A and cyclin B1 mRNA stability during cell proliferation. / EMBO J 2000,19(10):2340鈥?350. CrossRef
8. Suzuki M, Iijima M, Nishimura A, Tomozoe Y, Kamei D, Yamada M: Two separate regions essential for nuclear import of the hnRNP D nucleocytoplasmic shuttling sequence. / FEBS J 2005, 272:3975鈥?987. CrossRef
9. Fan XC, Steitz JA: HNS, a nuclear-cytoplasmic shuttling sequence in HuR. / Proc Natl Acad Sci U S A 1998, 95:15293鈥?5298. CrossRef
10. David PS, Tanveer R, Port JD: FRET-detectable interactions between the ARE binding proteins, HuR and p37AUF1. / RNA 2007, 13:1453鈥?468. CrossRef
11. Moraes KC, Quaresma AJ, Maehnss K, Kobarg J: Identification and characterization of proteins that selectively interact with isoforms of the mRNA binding protein AUF1 (hnRNP D). / Biol Chem 2003, 384:25鈥?7. CrossRef
12. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. / Nucleic Acids Res 1983, 11:1475鈥?489. CrossRef
13. Li M, Makkinje A, Damuni Z: Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A. / Biochemistry 1996, 35:6998鈥?002. CrossRef
14. Zhu T, Matsuzawa S, Mizuno Y, Kamibayashi C, Mumby MC, Andjelkovic N, Hemmings BA, Ono茅 K, Kikuchi K: The interconversion of protein phosphatase 2A between PP2A1 and PP2A0 during retinoic acid-induced granulocytic differentiation and a modification on the catalytic subunit in S phase of HL-60 cells. / Arch Biochem Biophys 1997, 339:210鈥?17. CrossRef
15. Millward TA, Zolnierowicz S, Hemmings BA: Regulation of protein kinase cascades by protein phosphatase 2A. / Trends Biochem Sci 1999, 24:186鈥?91. CrossRef
16. Chang N, Yi J, Guo G, Liu X, Shang Y, Tong T, Cui Q, Zhan M, Gorospe M, Wang W: HuR uses AUF1 as a cofactor to promote p16INK4 mRNA decay. / Mol Cell Biol 2010, 30:3875鈥?886. CrossRef
17. Bakheed T, Frevel M, Williams BR, Greer W, Khabar KS: ARED: human AU-rich element containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. / Nucleic Acids Res 2001, 29:246鈥?54. CrossRef
18. Gruber AR, Fallmann J, Kratochvill F, Kovarik P, Hofacker IL: AREsite: a database for the comprehensive investigation of AU-rich elements. / Nucleic Acids Res 2011,39(Database issue):D66鈥?. CrossRef
19. L贸pez de Silanes I, Zhan M, Lal A, Yang X, Gorospe M: Identification of a target RNA motif for RNA-binding protein HuR. / Proc Natl Acad Sci U S A 2004, 101:2987鈥?992. CrossRef
20. Mazan-Mamczarz K, Kuwano Y, Zhan M, White EJ, Martindale JL, Lal A, Gorospe M: Identification of a signature motif in target mRNAs of RNA-binding protein AUF1. / Nucleic Acids Res 2009, 37:204鈥?14. CrossRef
21. Gouble A, Morello D: Synchronous and regulated expression of two AU-binding proteins, AUF1 and HuR, throughout murine development. / Oncogene 2000, 19:5377鈥?384. CrossRef
22. Hambardzumyan D, Sergent-Tanguy S, Thinard R, Bonnamain V, Masip M, Fabre A, Boudin H, Neveu I, Naveilhan P: AUF1 and Hu proteins in the developing rat brain: implication in the proliferation and differentiation of neural progenitors. / J Neurosci Res 2009, 87:1296鈥?309. CrossRef
23. V谩zquez-Chantada M, Fern谩ndez-Ramos D, Embade N, Mart铆nez-Lopez N, Varela-Rey M, Woodhoo A, Luka Z, Wagner C, Anglim PP, Finnell RH, Caballer铆a J, Laird-Offringa IA, Gorospe M, Lu SC, Mato JM, Mart铆nez-Chantar ML: HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. / Gastroenterology 2010, 138:1943鈥?953. CrossRef
24. Sadri N, Schneider RJ: Auf1/Hnrnpd-deficient mice develop pruritic inflammatory skin disease. Auf1/Hnrnpd-deficient mice develop pruritic inflammatory skin disease. / J Invest Dermatol 2009, 129:657鈥?70. CrossRef
25. Cunningham MJ, Zone JJ: Thyroid abnormalities in dermatitis herpetiformis. Prevalence of clinical thyroid disease and thyroid autoantibodies. / Ann Intern Med 1985, 102:194鈥?96.
26. Artantas S, G眉l U, Kili莽 A, G眉ler S: Skin findings in thyroid diseases. / Eur J Intern Med 2009, 20:158鈥?61. CrossRef
27. Lu JY, Sadri N, Schneider RJ: Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. / Genes Dev 2006, 20:3174鈥?184. CrossRef
28. Sadri N, Lu JY, Badura ML, Schneider RJ: AUF1 is involved in splenic follicular B cell maintenance. / BMC Immunol 2010, 11:1. CrossRef
29. Katsanou V, Milatos S, Yiakouvaki A, Sgantzis N, Kotsoni A, Alexiou M, Harokopos V, Aidinis V, Hemberger M, Kontoyiannis DL: The RNA-binding protein Elavl1/HuR is essential for placental branching morphogenesis and embryonic development. / Mol Cell Biol 2009, 29:2762鈥?776. CrossRef
30. Krane IM, Spindel ER, Chin WW: Thyroid hormone decreases the stability and the poly(A) tract length of rat thyrotropin beta-subunit messenger RNA. / Mol Endocrinol 1991, 5:469鈥?75. CrossRef
31. Staton JM, Leedman PJ: Posttranscriptional regulation of thyrotropin beta-subunit messenger ribonucleic acid by thyroid hormone in murine thyrotrope tumor cells: a conserved mechanism across species. / Endocrinology 1998, 139:1093鈥?100. CrossRef
32. Goulart-Silva F, de Souza PB, Nunes MT: T3 rapidly modulates TSH尾 mRNA stability and translational rate in the pituitary of hypothyroid rats. / Mol Cell Endocrinol 2011, 332:277鈥?82. CrossRef
33. Leedman PJ, Stein AR, Chin WW: Regulated specific protein binding to a conserved region of the 3'-untranslated region of thyrotropin beta-subunit mRNA. / Mol Endocrinol 1995, 9:375鈥?87. CrossRef
34. Murphy D, Pardy K, Seah V, Carter D: Posttranscriptional regulation of rat growth hormone gene expression: increased message stability and nuclear polyadenylation accompany thyroid hormone depletion. / Mol Cell Biol 1992, 12:2624鈥?632.
35. Silva FG, Giannocco G, Luchessi AD, Curi R, Nunes MT: T3 acutely increases GH mRNA translation rate and GH secretion in hypothyroid rats. / Mol Cell Endocrinol 2010, 317:1鈥?. CrossRef
36. Minamisawa S, Uemura N, Sato Y, Yokoyama U, Yamaguchi T, Inoue K, Nakagome M, Bai Y, Hori H, Shimizu M, Mochizuki S, Ishikawa Y: Post-transcriptional downregulation of sarcolipin mRNA by triiodothyronine in the atrial myocardium. / FEBS Lett 2006, 580:2247鈥?252. CrossRef
37. Blum JL, Samarel AM, Mestril R: Phosphorylation and binding of AUF1 to the 3'-untranslated region of cardiomyocyte SERCA2a mRNA. / Am J Physiol Heart Circ Physiol 2005, 289:H2543鈥?550. CrossRef
38. Zhou C, Vignere CZ, Levitan ES: AUF1 is upregulated by angiotensin II to destabilize cardiac Kv4.3 channel mRNA. / J Mol Cell Cardiol 2008, 45:832鈥?38. CrossRef
39. Steinsapir J, Harney J, Larsen PR: Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes. / J Clin Invest 1998, 102:1895鈥?899. CrossRef
40. Gereben B, Goncalves C, Harney JW, Larsen PR, Bianco AC: Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. / Mol Endocrinol 2000, 14:1697鈥?708. CrossRef
41. Curcio-Morelli C, Zavacki AM, Christofollete M, Gereben B, de Freitas BC, Harney JW, Li Z, Wu G, Bianco AC: Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. / J Clin Invest 2003, 112:189鈥?96.
42. Sagar GD, Gereben B, Callebaut I, Mornon JP, Ze枚ld A, da Silva WS, Luongo C, Dentice M, Tente SM, Freitas BC, Harney JW, Zavacki AM, Bianco AC: Ubiquitination-induced conformational change within the deiodinase dimer is a switch regulating enzyme activity. / Mol Cell Biol 2007, 27:4774鈥?783. CrossRef
43. Martinez de Mena R, Scanlan TS, Obregon MJ: The T3 receptor beta1 isoform regulates UCP1 and D2 deiodinase in rat brown adipocytes. / Endocrinology 2010, 151:5074鈥?083. CrossRef
44. Navarro-Yubero C, Cuadrado A, Sonderegger P, Mu帽oz A: Neuroserpin is post-transcriptionally regulated by thyroid hormone. / Brain Res Mol Brain Res 2004, 123:56鈥?5. CrossRef
45. Mano H, Mori R, Ozawa T, Takeyama K, Yoshizawa Y, Kojima R, Arao Y, Masushige S, Kato S: Positive and negative regulation of retinoid X receptor gene expression by thyroid hormone in the rat. Transcriptional and post-transcriptional controls by thyroid hormone. / J Biol Chem 1994, 269:1591鈥?594.
46. Schmutzler C, Mentrup B, Schomburg L, Hoang-Vu C, Herzog V, K枚hrle J: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. / Biol Chem 2007, 388:1053鈥?059. CrossRef
47. Naveh-Many T, Bell O, Silver J, Kilav R: Cis and trans acting factors in the regulation of parathyroid hormone (PTH) mRNA stability by calcium and phosphate. / FEBS Lett 2002, 529:60鈥?4. CrossRef
48. Owen D, K眉hn LC: Noncoding 3' sequences of the transferrin receptor gene are required for mRNA regulation by iron. / EMBO J 1987, 6:1287鈥?293.
49. Mittag J, Behrends T, Hoefig CS, Vennstr枚m B, Schomburg L: Thyroid hormones regulate selenoprotein expression and selenium status in mice. / PLoS One 2010, 5:e12931. CrossRef
50. Sela-Brown A, Silver J, Brewer G, Naveh-Many T: Identification of AUF1 as a parathyroid hormone mRNA 3'-untranslated region-binding protein that determines parathyroid hormone mRNA stability. / J Biol Chem 2000, 275:7424鈥?429. CrossRef
51. Bermano G, Arthur JR, Hesketh JE: Selective control of cytosolic glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase mRNA stability by selenium supply. / FEBS Lett 1996, 387:157鈥?60. CrossRef
52. Riese C, Michaelis M, Mentrup B, G枚tz F, K枚hrle J, Schweizer U, Schomburg L: Selenium-dependent pre- and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues. / Endocrinology 2006, 147:5883鈥?892. CrossRef
53. Serrano-Nascimento C, Calil-Silveira J, Nunes MT: Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration. / Am J Physiol Cell Physiol 2010, 298:C893-C899. CrossRef
54. Trojanowicz B, Brodauf L, Sekulla C, Lorenz K, Finke R, Dralle H, Hoang-Vu C: The role of AUF1 in thyroid carcinoma progression. / Endocr Relat Cancer 2009, 16:857鈥?71. CrossRef
55. Braun J, Hoang-Vu C, Dralle H, H眉ttelmaier S: Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. / Oncogene 2010, 29:4237鈥?244. CrossRef
56. Trojanowicz B, Fu T, Gimm O, Sekulla C, Finke R, Dralle H, Hoang-Vu C: Relationship between RKIP protein expression and clinical staging in thyroid carcinoma. / Open Endocrinology Journal 2008, 2:16鈥?0. CrossRef
57. Trojanowicz B, Winkler A, Hammje K, Chen Z, Sekulla C, Glanz D, Schmutzler C, Mentrup B, Hombach-Klonisch S, Klonisch T, Finke R, K枚hrle J, Dralle H, Hoang-Vu C: Retinoic acid mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines. / J Mol Endocrinol 2009, 42:249鈥?60. CrossRef
58. Chen Z, Mustafa T, Trojanowicz B, Brauckhoff M, Gimm O, Schmutzler C, K枚hrle J, Holzhausen HJ, Kehlen A, Klonisch T, Finke R, Dralle H, Hoang-Vu C: CD82, and CD63 in thyroid cancer. / Int J Mol Med 2004, 14:517鈥?27.
59. Lengfelder E, Saussele S, Weisser A, Buchner T, Hehlmann R: Treatment concepts of acute promyelocytic leukemia. / Crit Rev Oncol Hematol 2005, 56:261鈥?74. CrossRef
60. Hansen LA, Sigman CC, Andreola F, Ross SA, Kelloff GJ, De Luca LM: Retinoids in chemoprevention and differentiation therapy. / Carcinogenesis 2000, 21:1271鈥?279. CrossRef
61. Simon D, K枚rber C, Krausch M, Segering J, Groth P, G枚rges R, Gr眉nwald F, M眉ller-G盲rtner HW, Schmutzler C, K枚hrle J, R枚her HD, Reiners C: Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. / Eur J Nucl Med Mol Imaging 2002, 29:775鈥?82. CrossRef
62. Handkiewicz-Junak D, Roskosz J, Hasse-Lazar K, Szpak-Ulczok S, Puch Z, Kukulska A, Olczyk T, Piela A, Paliczka-Cieslik E, Jarzab B: 13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study. / Thyroid Res 2009, 2:8. CrossRef
63. Fern谩ndez CA, Puig-Domingo M, Lome帽a F, Estorch M, Camacho Mart铆 V, Bittini AL, Marazuela M, Santamar铆a J, Castro J, Mart铆nez de Icaya P, Moraga I, Mart铆n T, Meg铆a A, Porta M, Mauricio D, Halperin I: Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake. / J Endocrinol Invest 2009, 32:228鈥?33.
64. Schmutzler C, Kohrle J: Retinoic acid redifferentiation therapy for thyroid cancer. / Thyroid 2000, 10:393鈥?06. CrossRef
65. Schmutzler C, Hoang-Vu C, R眉ger B, Kohrle J: Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid responses. / Eur J Endocrinol 2004, 150:547鈥?56. CrossRef
66. Trojanowicz B, Sekulla C, Lorenz K, K枚hrle J, Finke R, Dralle H, Hoang-Vu C: Proteomic approach reveals novel targets for retinoic acid-mediated therapy of thyroid carcinoma. / Mol Cell Endocrinol 2010, 325:110鈥?17. CrossRef
67. Gouble A, Grazide S, Meggetto F, Mercier P, Delsol G, Morello D: A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice. / Cancer Res 2002, 62:1489鈥?495.
68. Blaxall BC, Dwyer-Nield LD, Bauer AK, Bohlmeyer TJ, Malkinson AM, Port JD: Differential expres-sion and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. / Mol Carcinog 2000, 28:76鈥?3. CrossRef
69. Yuan Z, Sanders AJ, Ye L, Jiang WG: HuR, a key post-transcriptional regulator, and its implication in progression of breast cancer. / Histol Histopathol 2010, 25:1331鈥?340.
70. Kakuguchi W, Kitamura T, Kuroshima T, Ishikawa M, Kitagawa Y, Totsuka Y, Shindoh M, Higashino F: HuR knockdown changes the oncogenic potential of oral cancer cells. / Mol Cancer Res 2010, 8:520鈥?28. CrossRef
71. Fawal M, Armstrong F, Ollier S, Dupont H, Touriol C, Monsarrat B, Delsol G, Payrastre B, Morello D: A "liaison dangereuse" between AUF1/hnRNPD and the oncogenic tyrosine kinase NPM-ALK. / Blood 2006, 108:2780鈥?788. CrossRef
72. Paek KY, Kim CS, Park SM, Kim JH, Jang SK: RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA. / J Virol 2008, 82:12082鈥?2093. CrossRef
73. Weinlich S, H眉ttelmaier S, Schierhorn A, Behrens SE, Ostareck-Lederer A, Ostareck DH: IGF2BP1 enhances HCV IRES-mediated translation initiation via the 3'UTR. / RNA 2009, 15:1528鈥?542. CrossRef
74. Kang X, Chen W, Kim RH, Kang MK, Park NH: Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells. / Oncogene 2009, 28:565鈥?74. CrossRef
75. Lin S, Wang W, Wilson GM, Yang X, Brewer G, Holbrook NJ, Gorospe M: Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover. / Mol Cell Biol 2000, 20:7903鈥?913. CrossRef
76. Brewer G, Saccani S, Sarkar S, Lewis A, Pestka S: Increased interleukin-10 mRNA stability in melanoma cells is associated with decreased levels of A + U-rich element binding factor AUF1. / J Interferon Cytokine Res 2003, 23:553鈥?64. CrossRef
77. Skriner K, Hueber W, S眉leymanoglu E, H枚fler E, Krenn V, Smolen J, Steiner G: AUF1, the regulator of tumor necrosis factor alpha messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases. / Arthritis Rheum 2008, 58:511鈥?20. CrossRef
78. Nabors LB, Furneaux HM, King PH: HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues. / J Neuroimmunol 1998, 92:152鈥?59. CrossRef
79. Masuda K, Abdelmohsen K, Gorospe M: RNA-binding proteins implicated in the hypoxic response. / J Cell Mol Med 2009, 13:2759鈥?769. CrossRef
80. Ghosh M, Aguila HL, Michaud J, Ai Y, Wu MT, Hemmes A, Ristimaki A, Guo C, Furneaux H, Hla T: Essential role of the RNA-binding protein HuR in progenitor cell survival in mice. / J Clin Invest 2009, 119:3530鈥?543. CrossRef
81. Wang W, Martindale JL, Yang X, Chrest FJ, Gorospe M: Increased stability of the p16 mRNA with replicative senescence. / EMBO Rep 2005, 6:158鈥?64. CrossRef
82. Guo GE, Ma LW, Jiang B, Yi J, Tong TJ, Wang WG: Hydrogen peroxide induces p16(INK4a) through an AUF1-dependent manner. / J Cell Biochem 2010, 109:1000鈥?005.
83. Yi J, Chang N, Liu X, Guo G, Xue L, Tong T, Gorospe M, Wang W: Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence. / Nucleic Acids Res 2010, 38:1547鈥?558. CrossRef
84. Nagaoka K, Tanaka T, Imakawa K, Sakai S: Involvement of RNA binding proteins AUF1 in mammary gland differentiation. / Exp Cell Res 2007, 313:2937鈥?945. CrossRef
85. Klonisch T, Hoang-Vu C, Hombach-Klonisch S: Thyroid stem cells and cancer. / Thyroid 2009, 19:1303鈥?315. CrossRef - 作者单位：Bogusz Trojanowicz (1)
Henning Dralle (1)
Cuong Hoang-Vu (1)
1. Universit盲tsklinik und Poliklinik f眉r Allgemein-, Viszeral- und Gef盲脽chirurgie, Martin-Luther Universit盲t, Halle, Germany
文摘
RNA-binding proteins may regulate every aspect of RNA metabolism, including pre-mRNA splicing, mRNA trafficking, stability and translation of many genes. The dynamic association of these proteins with RNA defines the lifetime, cellular localization, processing and the rate at which a specific mRNA is translated. One of the pathways involved in regulating of mRNA stability is mediated by adenylate uridylate-rich element (ARE) binding proteins. These proteins are involved in processes of apoptosis, tumorigenesis and development. Out of many ARE-binding proteins, two of them AUF1 and HuR were studied most extensively and reported to regulate the mRNA stability in vivo. Our previously published data demonstrate that both proteins are involved in thyroid carcinogenesis. Several other reports postulate that mRNA binding proteins may participate in thyroid hormone actions. However, until now, exacts mechanisms and the possible role of post-transcriptional regulation and especially the role of AUF1 and HuR in those processes remain not fully understood. In this study we shortly review the possible function of both proteins in relation to development and various physiological and pathophysiological processes, including thyroid function and disorders.